XML 72 R41.htm IDEA: XBRL DOCUMENT v3.25.3
SHARE-BASED COMPENSATION (Tables)
 12 Months Ended
Oct. 03, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation Expense
The following table summarizes the share-based compensation expense (reversal) and related information for time-based options (“TBOs”), time-based restricted stock units (“RSUs”), performance stock units (“PSUs”), deferred stock units (“DSUs”) and the Employee Stock Purchase Plan (“ESPP”) classified as “Selling, general and administrative expenses” on the Consolidated and Combined Statements of Income (in thousands).
Fiscal Year Ended
October 3, 2025September 27, 2024September 29, 2023
TBOs(1)
$4,688 $3,960 $1,125 
RSUs(2)
7,774 6,654 8,013 
PSUs(3)
(897)4,264 866 
DSUs(4)
— 1,458 — 
ESPP(5)
— — 597 
$11,565 $16,336 $10,601 
Income tax benefit related to share-based compensation$3,342 $3,180 $2,568 
__________________
(1)The increase in share-based compensation expense related to TBOs during both fiscal 2025 and fiscal 2024 compared to the respective prior year were each due to increases in grants in those years, when compared with the respective prior period.
(2)Share-based compensation expense for RSUs increased in fiscal 2025 compared to fiscal 2024 due to an increase in the number of RSU grants in fiscal 2025. The decrease during fiscal 2024 compared to fiscal 2023 was due to a decrease in RSU awards in fiscal 2024 compared to prior years.
(3)Share-based compensation expense for PSUs decreased in fiscal 2025 due to adjustments to reflect expected payouts. The increase during fiscal 2024 compared to fiscal 2023 was due to an increase in grants issued in fiscal 2024 compared to fiscal 2023.
(4)No DSUs were granted in fiscal 2025 or fiscal 2023.
(5)The Company does not currently have an ESPP.
Schedule of Unrecognized Compensation Expense Non-vested Award
The below table summarizes the unrecognized compensation expense as of October 3, 2025 related to non-vested awards and the weighted-average period they are expected to be recognized:
Unrecognized Compensation Expense
(in thousands)		Weighted-Average Period
(Years)
TBOs$3,494 1.91
RSUs14,024 1.83
PSUs$256 1.35
Total$17,774 
Schedule of Weighted Average Assumptions and Related Valuations for TBOs
The table below presents the weighted average assumptions and related valuations for TBOs.
Fiscal Year Ended
October 3, 2025September 27, 2024September 29, 2023
Expected volatility
31.3% - 31.8%
32.3% - 33.5%
42.0 %
Expected dividend yield
0.9% - 1.2%
—% - 0.8%
1.0% - 1.2%
Expected life (in years)
6.0 - 6.0
6.0 - 6.5
6.3
Risk-free interest rate
4.1% - 4.4%
4.1% - 4.7%
3.7% - 4.2%
Weighted-average grant-date fair value$6.9 $6.5 $16.9 
Schedule of TBO Activity
A summary of TBO activity is presented below:
OptionsShares
(000s)		Weighted-Average Exercise PriceAggregate Intrinsic Value
($000s)		Weighted-Average Remaining Term
(Years)
Outstanding at October 2, 2023(1)
523$18.59 
Granted1,768$19.42 
Exercised(10)$13.88 
Forfeited and expired(353)$19.57 
Outstanding at September 27, 20241,928$19.20 $44 8.4
Granted1,104$15.78 
Exercised(23)$14.33 
Forfeited and expired(1,666)$18.60 
Outstanding at October 03, 20251,343$17.28 $— 8.0
Exercisable at October 03, 2025196$18.76 $— 5.6
Expected to vest at October 03, 20251,147$16.95 $— 8.5
__________________
(1)On October 2, 2023, our common stock began trading on the New York Stock Exchange (“NYSE”). The shares outstanding as of October 2, 2023 pertain to Aramark equity awards issued by Aramark in prior periods to employees of the Company that were converted to Vestis equity awards as part of the Separation.
Fiscal Year Ended
October 3, 2025September 27, 2024September 29, 2023
Total intrinsic value exercised (in thousands)$25 $63 $2,040 
Total fair value that vested (in thousands)1,172 774 1,106 
Schedule of Restricted Stock Unit Activity The unvested RSUs are subject to forfeiture if employment is terminated other than due to death, disability or retirement, and the RSUs are nontransferable while subject to forfeiture.
Restricted Stock UnitsUnits
(000s)		Weighted Average Grant-Date Fair Value
Outstanding at October 2, 2023(1)
850$18.90 
Granted492$17.71 
Vested(369)$18.81 
Forfeited(135)$19.08 
Outstanding at September 27, 2024838$18.22 
Granted2,195$8.56 
Vested(484)$17.95 
Forfeited(399)$14.70 
Outstanding at October 03, 20252,150$9.07 
__________________
(1)On October 2, 2023, our common stock began trading on the New York Stock Exchange (“NYSE”). The shares outstanding as of October 2, 2023 pertain to Aramark equity awards issued by Aramark in prior periods to employees of the Company that were converted to Vestis equity awards as part of the Separation.
Fiscal Year Ended
October 3, 2025September 27, 2024September 29, 2023
Total fair value that vested (in thousands)$8,680 $6,950 $9,396 
Schedule of Performance Stock Unit Activity Any unvested PSUs are subject to forfeiture if employment is terminated other than due to death, disability or retirement, and the PSUs are nontransferable while subject to forfeiture.
Performance Stock UnitsUnits
(000s)		Weighted Average Grant-Date Fair Value
Outstanding at October 2, 2023(1)
177$21.87 
Granted663$17.86 
Vested—$— 
Forfeited(142)$18.63 
Outstanding at September 27, 2024698$18.76 
Granted346$16.74 
Vested—$— 
Forfeited(394)$18.14 
Outstanding at October 03, 2025650$17.90 
__________________
(1)On October 2, 2023, our common stock began trading on the New York Stock Exchange (“NYSE”). The shares outstanding as of October 2, 2023 pertain to Aramark equity awards issued by Aramark in prior periods to employees of the Company that were converted to Vestis equity awards as part of the Separation.